Abiopharma

🔍 Osben Teo (Executive)

Company: Ralliant Corp (RAL)

Report Date: 2026-06-23

Detailed Transactions and Holdings:

• Acquired 4 shares of Executive Deferred Incentive Program - Ralliant Stock Fund (Derivative)
  Date: 2026-06-23 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,440.20 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3

Footnotes:

• F1: The reported securities are notional dividend accruals on phantom shares in the Issuer stock fund (the "EDIP Stock Fund") under the Issuer's Executive Deferred Incentive Program (the "EDIP"). The number of phantom shares accrued as a result of such notional dividend accruals is based on the closing price of the Issuer's common stock as reported on the NYSE on the date such dividend accruals are credited to the EDIP Stock Fund, which closing price is shown in Table II, Column 8.
• F2: The notional shares settle in shares of the Issuer's common stock on a one-to-one basis.
• F3: The Reporting Person immediately vests in 100% of each voluntary contribution to the EDIP Stock Fund. The Reporting Person will vest in all contributions to the EDIP Stock Fund by the Issuer as follows: 100% upon the earlier of the Reporting Person's death, or upon retirement following at least five years of service with the Issuer and reaching the age of 55, or, if earlier, one-tenth per year of participation following five years of participation, in each case in accordance with the EDIP. Upon termination of employment, the vested portion of the EDIP Stock Fund is settled in the Issuer's common stock.